OBJECTIVE

Diabetes distress (DD) is the negative emotional toll of living with or caring for type 1 diabetes, encompassing the pervasiveness of its daily demands. We recently developed Remedy to Diabetes Distress (R2D2), a screen-to-treat intervention for families of school-aged children with type 1 diabetes. This article reports on the use of crowdsourcing methods to design the intervention and capture the voice of parent stakeholders.

RESEARCH DESIGN AND METHODS

We recruited 41 parents of 8- to 12-year-olds with type 1 diabetes. In a secure online social network, we posted study questions to participants, who could respond to our questions and view and comment on other participants’ responses (i.e., participants could interact as a “crowd”). An iterative approach allowed our questions to move from broad to specific, enabling parent input on treatment content.

RESULTS

Using a conceptual model of DD, we examined responses and applied codes to distill qualitative categories. We established substantial agreement on identified categories, with fidelity at κ = 0.615. In addition to providing broad feedback (e.g., on preferred language for common phrases used in type 1 diabetes interventions), parents also provided feedback on specific treatment components and the overall tone of the intervention. Parents highlighted benefit-finding and positive talk/self-talk as pertinent for incorporation into treatment.

CONCLUSION

This study illustrates the use of crowdsourcing methods to capture the voices of parents of school-aged children with type 1 diabetes when designing a DD intervention. The next phase of R2D2 will be a small pre-trial to evaluate the feasibility and acceptability of the intervention, followed by a proof-of-concept randomized controlled trial (RCT), during which family voices will continue to be incorporated.

This content is only available via PDF.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.
You do not currently have access to this content.